ProShare Advisors LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$596,976
+19.8%
5,855
+6.9%
0.00%0.0%
Q1 2023$498,151
+112.1%
5,479
-11.4%
0.00%
+100.0%
Q4 2022$234,854
-14.9%
6,182
-26.5%
0.00%0.0%
Q1 2022$276,000
+0.4%
8,407
-19.4%
0.00%0.0%
Q4 2021$275,000
-73.3%
10,428
+1.9%
0.00%
-66.7%
Q3 2021$1,030,000
-43.0%
10,238
-19.8%
0.00%
-40.0%
Q2 2021$1,806,000
+322.0%
12,759
+197.3%
0.01%
+400.0%
Q1 2021$428,000
-22.2%
4,291
-3.6%
0.00%
-50.0%
Q4 2020$550,000
+22.8%
4,451
-3.3%
0.00%0.0%
Q3 2020$448,000
-36.2%
4,602
+2.3%
0.00%
-50.0%
Q2 2020$702,000
-4.9%
4,500
-12.0%
0.00%
-20.0%
Q1 2020$738,000
-59.8%
5,116
-43.1%
0.01%
-44.4%
Q4 2019$1,837,000
+156.6%
8,988
+0.8%
0.01%
+125.0%
Q3 2019$716,000
-16.8%
8,917
-2.3%
0.00%
-20.0%
Q2 2019$861,000
-1.6%
9,130
-10.8%
0.01%0.0%
Q1 2019$875,000
+54.3%
10,234
+1.3%
0.01%
+25.0%
Q4 2018$567,000
-42.0%
10,101
-15.6%
0.00%
-42.9%
Q3 2018$978,000
+164.3%
11,964
+13.1%
0.01%
+250.0%
Q2 2018$370,000
+69.7%
10,576
-0.4%
0.00%
+100.0%
Q1 2018$218,000
-37.7%
10,621
-14.1%
0.00%
-50.0%
Q4 2017$350,00012,3700.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders